Orange Book product · Brand (NDA)
DEHYDRATED ALCOHOL
DEHYDRATED ALCOHOL
At a glance
Oct 23, 2025
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 23, 2025
8 mo ago
Today
Exclusivity ends · ODE-521
Orphan-drug exclusivity (7 years)
Oct 23, 2032
in 6 yr 5 mo
Pharmaceutical detail
Active ingredient
DEHYDRATED ALCOHOL
Strength
98% (5ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
Not listed
Application
NDA 214988
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2018ABLYSINOLBrand (NDA)
NDA 207987 · BPI LABS
- 2025DEHYDRATED ALCOHOLGeneric (ANDA)
ANDA 219569 · INGENUS PHARMS LLC
- 2025DEHYDRATED ALCOHOLGeneric (ANDA)
ANDA 217845 · ACCORD HLTHCARE
- 2025DEHYDRATED ALCOHOLGeneric (ANDA)
ANDA 219444 · BRECKENRIDGE
- 2025DEHYDRATED ALCOHOLGeneric (ANDA)
ANDA 219400 · XGEN PHARMS
Marketing exclusivity (1)
- ODE-521Orphan-drug exclusivity (7 years)
Oct 23, 2032
in 6 yr 5 mo
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

